Recurrent Dermatofibrosarcoma protuberans
Drug | Drug Name | Drug Description |
---|---|---|
DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |
Drug | Drug Name | Phase | Status | Count |
---|